Innovative patient education and pain management protocols to achieve opioid-free shoulder arthroplasty

Vani J Sabesan, Kiran Chatha, Sandra Koen, Mirelle Dawoud, Gregory Gilot, Vani J Sabesan, Kiran Chatha, Sandra Koen, Mirelle Dawoud, Gregory Gilot

Abstract

Background: The creation of pain as the fifth vital sign led to skyrocketing opioid prescriptions and a crisis with addiction and abuse among Americans. The purpose of this study was to evaluate the effectiveness of a patient engagement model including education and innovative opioid-free multimodal pain management to achieve an opioid-free recovery after shoulder arthroplasty (SA).

Methods: Fifty patients undergoing SA were divided into 2 groups. In the opioid-free group (OFG), patients received additional preoperative education in combination with an innovative non-opioid multimodal pain management protocol and non-opioid alternatives. Patients were compared regarding pain levels and opioid consumption at 48 hours and at 2 weeks, as well as patient-reported outcome measures, using Student t tests.

Results: No significant differences were found in age (average, 69.76 years) (P = .14), American Society of Anesthesiologists grade (average, 2.25) (P = .24), sex, body mass index (average, 29.5) (P = .34), or comorbidity burden. In the OFG, 24% of patients reported use of rescue opioids (<2 pills) within the first 48 hours after surgery with complete cessation by 2 weeks postoperatively. Comparatively, in the control group, 100% of patients reported using opioids in the first 48 hours after surgery and 80% reported still taking opioids at 2 weeks postoperatively. Patients in both groups showed significant improvements in outcome scores (P ≤ .05), with the OFG reporting significantly higher American Shoulder and Elbow Surgeons pain (P = .036) and Constant (P = .005) scores.

Conclusions: Our findings support complete elimination of opioid use by 2 weeks after SA using a patient engagement model with non-opioid-based alternative pain management. The elimination of opioid pain management did not diminish outcomes or patient satisfaction after SA.

Keywords: Opioid use; non-opioid alternatives; opioid dependence; pain management; patient education; shoulder arthroplasty.

© 2020 Published by Elsevier Inc. on behalf of American Shoulder and Elbow Surgeons.

Figures

Figure 1
Figure 1
Opioid consumption compared between groups in immediate postoperative period.

References

    1. Aasvang E.K., Lunn T.H., Hansen T.B., Kristensen P.W., Solgaard S., Kehlet H. Chronic preoperative opioid use and acute pain after fast-track total knee arthroplasty. Acta Anaesthesiol Scand. 2016;60:529–536. doi: 10.1111/aas.12667.
    1. Ardon A.E., Greengrass R.A., Bhuria U., Porter S.B., Robards C.B., Blasser K. The use of paravertebral blockade for analgesia after anterior-approach total hip arthroplasty. Middle East J Anaesthesiol. 2015;23:81–89.
    1. Becchi C., Al Malyan M., Coppini R., Campolo M., Magherini M., Boncinelli S. Opioid-free analgesia by continuous psoas compartment block after total hip arthroplasty. A randomized study. Eur J Anaesthesiol. 2008;25:418–423. doi: 10.1017/s026502150700302x.
    1. Berglund D.D., Rosas S., Kurowicki J., Mijic D., Levy J.C. Effect of opioid dependence or abuse on opioid utilization after shoulder arthroplasty. World J Orthop. 2018;9:105–111. doi: 10.5312/wjo.v9.i8.105.
    1. Cheah J.W., Sing D.C., McLaughlin D., Feeley B.T., Ma C.B., Zhang A.L. The perioperative effects of chronic preoperative opioid use on shoulder arthroplasty outcomes. J Shoulder Elbow Surg. 2017;26:1908–1914. doi: 10.1016/j.jse.2017.05.016.
    1. Clarke H., Soneji N., Ko D.T., Yun L., Wijeysundera D.N. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ. 2014;348:g1251. doi: 10.1136/bmj.g1251.
    1. E-FORCSE . Florida State Department of Health; 2019. Florida Prescription Drug Monitoring Program.
    1. Guy G.P., Jr., Zhang K., Bohm M.K., Losby J., Lewis B., Young R. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66:697–704. doi: 10.15585/mmwr.mm6626a4.
    1. Leas D.P., Connor P.M., Schiffern S.C., D'Alessandro D.F., Roberts K.M., Hamid N. Opioid-free shoulder arthroplasty: a prospective study of a novel clinical care pathway. J Shoulder Elbow Surg. 2019;28:1716–1722. doi: 10.1016/j.jse.2019.01.013.
    1. Manchikanti L., Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008;11:S63–S88.
    1. Morris B.J., Sciascia A.D., Jacobs C.A., Edwards T.B. Preoperative opioid use associated with worse outcomes after anatomic shoulder arthroplasty. J Shoulder Elbow Surg. 2016;25:619–623. doi: 10.1016/j.jse.2015.09.017.
    1. Rao A.G., Chan P.H., Prentice H.A., Paxton E.W., Navarro R.A., Dillon M.T. Risk factors for postoperative opioid use after elective shoulder arthroplasty. J Shoulder Elbow Surg. 2018;27:1960–1968. doi: 10.1016/j.jse.2018.04.018.
    1. Smith D.H., Kuntz J., DeBar L., Mesa J., Yang X., Boardman D. A qualitative study to develop materials educating patients about opioid use before and after total hip or total knee arthroplasty. J Opioid Manag. 2018;14:183–190. doi: 10.5055/jom.2018.0448.
    1. Smith D.H., Kuntz J.L., DeBar L.L., Mesa J., Yang X., Schneider J. A randomized, pragmatic, pharmacist-led intervention reduced opioids following orthopedic surgery. Am J Manag Care. 2018;24:515–521.
    1. Sun E.C., Darnall B.D., Baker L.C., Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med. 2016;176:1286–1293. doi: 10.1001/jamainternmed.2016.3298.
    1. Syed U.A.M., Aleem A.W., Wowkanech C.D., Weekes D., Freedman M., Pepe M.D. The effect of preoperative education on opioid consumption in patients undergoing arthroscopic rotator cuff repair: a prospective, randomized control trial. J Shoulder Elbow Surg. 2018;27:e123. doi: 10.1016/j.jse.2018.02.009.
    1. Tashjian R.Z., Hung M., Keener J.D., Bowen R.C., McAllister J., Chen W. Determining the minimal clinically important difference for the American Shoulder and Elbow Surgeons score, Simple Shoulder Test, and visual analog scale (VAS) measuring pain after shoulder arthroplasty. J Shoulder Elbow Surg. 2017;26:144–148. doi: 10.1016/j.jse.2016.06.007.
    1. Tedesco D., Gori D., Desai K.R., Asch S., Carroll I.R., Curtin C. Drug-free interventions to reduce pain or opioid consumption after total knee arthroplasty: a systematic review and meta-analysis. JAMA Surg. 2017;152:e172872. doi: 10.1001/jamasurg.2017.2872.
    1. Vowles K.E., McEntee M.L., Julnes P.S., Frohe T., Ney J.P., van der Goes D.N. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156:569–576. doi: 10.1097/01.j.pain.0000460357.01998.f1.
    1. Wagner E.R., Welp K., Chang M.J., Woodmass J.M., Borque K.A., Warner J.J.P. Common pain generators after total shoulder arthroplasty and their pesky relatives. Semin Arthroplasty. 2017;28:166–174. doi: 10.1053/j.sart.2017.12.010.
    1. Westermann R.W., Anthony C.A., Bedard N., Glass N., Bollier M., Hettrich C.M. Opioid consumption after rotator cuff repair. Arthroscopy. 2017;33:1467–1472. doi: 10.1016/j.arthro.2017.03.016.
    1. Wide-ranging online data for epidemiologic research (WONDER) Centers for Disease Control and Prevention, National Center for Health Statistics; Atlanta, GA: 2017.
    1. Yorkgitis B.K., Brat G.A. Postoperative opioid prescribing: getting it RIGHTT. Am J Surg. 2018;215:707–711. doi: 10.1016/j.amjsurg.2018.02.001.
    1. Zywiel M.G., Stroh D.A., Lee S.Y., Bonutti P.M., Mont M.A. Chronic opioid use prior to total knee arthroplasty. J Bone Joint Surg Am. 2011;93:1988–1993. doi: 10.2106/jbjs.j.01473.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere